Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
36.46
+0.60 (1.67%)
Aug 13, 2025, 4:00 PM - Market closed
Acelyrin Employees
Royalty Pharma had 99 employees as of December 31, 2024. The number of employees increased by 10 or 11.24% compared to the previous year.
Employees
99
Change (1Y)
10
Growth (1Y)
11.24%
Revenue / Employee
$23,285,283
Profits / Employee
$10,310,364
Market Cap
21.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 99 | 10 | 11.24% |
Dec 31, 2023 | 89 | 14 | 18.67% |
Dec 31, 2022 | 75 | 9 | 13.64% |
Dec 31, 2021 | 66 | 15 | 29.41% |
Dec 31, 2020 | 51 | 16 | 45.71% |
Dec 31, 2019 | 35 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RPRX News
- 13 hours ago - Henry Fernandez Steps Down from Royalty Pharma's Board of Directors - GlobeNewsWire
- 4 days ago - Royalty Pharma: Keep Delivering, Buy Confirmed - Seeking Alpha
- 7 days ago - Royalty Pharma plc (RPRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Royalty Pharma Reports Second Quarter 2025 Results - GlobeNewsWire
- 26 days ago - Royalty Pharma Declares Third Quarter 2025 Dividend - GlobeNewsWire
- 27 days ago - Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company's Board of Directors - GlobeNewsWire
- 4 weeks ago - Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 6 weeks ago - Royalty Pharma: Attractive Acquisition With Upside Risk/Reward On Current Pipeline - Seeking Alpha